Coherus Oncology, Inc.CHRSNASDAQ
Loading
Income Before Tax Over TimeContracting
Percentile Rank46
Studio
Year-over-Year Change

Pre-tax earnings

Percentile
P46
Within normal range
vs 5Y Ago
-1.3x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$-183.12M-742.4%
2024$28.51M+112.0%
2023$-238.27M+18.3%
2022$-291.75M-1.6%
2021$-287.10M-311.6%
2020$135.71M+46.3%
2019$92.78M+144.3%
2018$-209.41M+12.1%
2017$-238.29M-86.5%
2016$-127.79M-